The first human trial of an antibody therapy to treat COVID-19 is underway, CNN reported Monday. According to drug maker Eli Lilly, the phase 1 trial is designed to find if the drug is safe
Human trial of antibody therapy to treat COVID-19 underway
Home »
New gene therapy for complete color blindness tested in patients
An initial trial in patients indicates that a new genetic treatment for complete color blindness, developed by research groups based in Tübingen and Munich is safe. Preliminary evidence for its efficacy has also been obtained.
New gene therapy method improves vision in mice with congenital blindness
Mice born blind have shown significant improvement in vision after undergoing a new gene therapy developed by a team of Japanese scientists. The results were published on January 24th in Nature Communications. This new method
Snake venom study reveals troubling shortcomings in antivenom therapy in India
Commercially available antivenoms in India can be ineffective in treating bites from certain medically important neglected snakes, a new study has shown. These snakes are those whose bites are harmful to humans, yet are poorly
This Is the Light Therapy Lamp Amazon Shoppers Swear By to Combat Seasonal Affective Disorder
As summer wanes and fall’s crisper winds usher us toward winter each year, seasonal affective Disorder (SAD) kicks in for millions of people. This type of depression typically recurs annually during the colder, darker months,
Researchers identify targeted therapy that can help children with deadly nerve cancer
Mount Sinai researchers have identified a targeted therapy for adolescent patients with neuroblastoma, a deadly pediatric nerve cancer, who would otherwise have no treatment options, according to a study published in October in Cancer Cell.
Gene therapy for Duchenne muscular dystrophy safely preserves muscle function
A gene therapy being developed at Penn Medicine to treat Duchenne muscular dystrophy (DMD) successfully and safely stopped the severe muscle deterioration associated with the rare, genetic disease in both small and large animal models,
Combo antithrombotic therapy increases bleeding risk
(HealthDay)—Patients with chronic coronary artery disease or peripheral artery disease treated with the combination of rivaroxaban and aspirin face a greater risk for bleeding versus patients treated with aspirin alone, according to a study published
Algorithm based on response, biology guides neuroblastoma therapy
(HealthDay)—Use of a response- and biology-based treatment algorithm for intermediate-risk neuroblastoma is associated with excellent survival and reduces treatment for some patients, according to a study published online Aug. 6 in the Journal of Clinical
Pioneering hair transplant therapy gets Government green light
Government gives green light for firm to BANK people’s frozen hair follicles for pioneering transplant therapy to combat baldness A company has been given permission by the Human Tissue Authority Cells within the follicles can